Navigation Links
Celsense, Inc Receives NIH Grant to Translate Cell Imaging Technology for Clinical Use
Date:6/2/2009

NIH funds human clinical testing of the cell trafficking MRI reagent, Cell Sense.

Pittsburgh, PA (Vocus) June 2, 2009 -- Celsense, Inc. announced today that it is one of the recipients in a 4-year $1.95M grant from the National Institutes of Health. The funded studies will be the first effort to evaluate Cell Sense, the Company’s fluorocarbon-based magnetic resonance imaging (MRI) cell tracking reagent, for clinical use. Additionally, the studies will garner preliminary data critically important for improving immunotherapeutic delivery strategies in metastatic colorectal (CRC) and other forms of cancer.

The Cell Sense technology makes transplanted cells visible by MRI. Therapeutic cells are labeled ex vivo with the Cell Sense reagent prior to administration to the patient. Cell migration and biodistribution are subsequently monitored using fluorine-19 (19F) MRI or magnetic resonance spectroscopy (MRS). The key advantage of Cell Sense is that the 19F images are extremely selective for the labeled cells, with no background signal from the host’s tissues. Furthermore, accurate cell quantification in regions of interest is possible.

Existing data from pre-clinical studies using human cells show that the Cell Sense reagent is highly biocompatible inside cells and does not affect their innate function. A clinical-grade version of the Cell Sense reagent has been formulated by Celsense, Inc. and is currently being subjected to mandatory in vitro and animal safety studies in preparation for human trials.

To conduct this project, Celsense has partnered with academia, including scientists at Carnegie Mellon University, where the imaging technology was invented in the laboratory of Dr. Ahrens. Also participating is the University of Pittsburgh Cancer Institute (UPCI) which is actively conducting clinical trials using immunotherapeutic dendritic cell (DC) vaccines
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
2. 500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device
3. SyntheMed Receives Australian Regulatory Approval for REPEL-CV(R)
4. Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients
5. Sanofi Pasteur Receives Seed Virus to Produce New Influenza A(H1N1) Vaccine
6. Genaera Receives Non-Compliance Notice from Nasdaq
7. AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support
8. Catalyst Pharmaceutical Partners Receives NASDAQ Deficiency Notice
9. NeurogesX Receives European Commission Approval for Qutenza(TM)
10. deCODE Genotyping Laboratory Receives College of American Pathologists Accreditation
11. GenVault Receives Four Critical U.S. and E.U. Patent Allowances for Key Biosample Management Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Celsense, Inc Receives NIH Grant to Translate Cell Imaging Technology for Clinical Use
(Date:10/20/2014)...  GenVec, Inc. (NASDAQ: GNVC ) today announced ... its board of directors effective on October 24, 2014.   Dr. ... as its chairman from June 2006 to November 2013.  During ... Governance and Audit Committees of the board.  ... dedicated service to GenVec, and its stockholders," said Wayne ...
(Date:10/20/2014)... N.J. (PRWEB) October 20, 2014 ... the Sidney Kimmel Cancer Center at Thomas Jefferson ... , Through the Strategic Alliance Partnership program, ... OncLive will collaborate to raise awareness of the ... treatment, and other projects. Clinicians and other health ...
(Date:10/20/2014)... OR (PRWEB) October 20, 2014 Local ... participate in an investigational study of donor stem cells ... in stem cell therapy and has performed clinical stem ... this study is to determine if a single injection ... affected joints can help reduce pain and inflammation in ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 ... Industry Meeting (ABIM). ABIM will take ... More information about ABIM 2014 is now ... , Delegates representing companies and organizations from ... and obtain information on the latest products ...
Breaking Biology Technology:Zola P. Horovitz To Retire From GenVec Board 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... - It has yet to turn a profit, and it operates ... but the decision by Madison research tool manufacturer NimbleGen Systems ... $75 million is the latest bit of evidence that the Wisconsin ... continues a pattern of growth and visibility for NimbleGen, which saw ...
... Glendale, Wis. - When it comes to health information ... side" of Wheaton Franciscan Healthcare is thinking. , ... system, has plenty of insights into the business side of ... administration, he once founded a computer resource business, and now ...
... spending in the healthcare industry is soaring, as are ... privacy, computerized physician order entry , and the ... operations faced by CIOs in other industries. , ,The ... what separates the men from the boys is that ...
Cached Biology Technology:IPO-bound NimbleGen traveling in fast company 2IPO-bound NimbleGen traveling in fast company 3IPO-bound NimbleGen traveling in fast company 4CIO Leadership Series: Greg Smith, Wheaton Franciscan Healthcare 2CIO Leadership Series: Greg Smith, Wheaton Franciscan Healthcare 3CIO Leadership Series: Greg Smith, Wheaton Franciscan Healthcare 4Fire your CIO? If he's not implementing strategy, show him the door 2Fire your CIO? If he's not implementing strategy, show him the door 3
(Date:10/18/2014)... with undiagnosed, suspected genetic conditions, a certain type of ... diagnostic yield than traditional molecular diagnostic methods, according to ... is being released to coincide with the American Society ... sequences the protein­coding region of the genome (the complete ... cell or organism), has been rapidly applied in research ...
(Date:10/17/2014)... German . ... in order to reproduce? And why are there two sexes ... latest issue of the research journal Molecular Human Reproduction ... Ramm from Bielefeld University Bielefeld has compiled this special issue ... a female to copulate with several males in quick succession ...
(Date:10/17/2014)... . To date, ... overdoses, doctors are often limited to supportive therapy such as ... combination of drugs involved. So what can be done if ... ETH professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences ... question. "The task was to develop an agent that could ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
... Corporate Safe Specialists (CSS),announces an addition to ... Ladd as National Account Manager., (Photo: ... James Currey, Sales Manager of the Company, stated, ... further accelerate the growth we,ve seen in,networked safe ...
... long observed that when food becomes scarce, animal populations ... studying southern sea otters at different sites in California,s ... dietary diversity of the population is higher where food ... the diets of individual sea otters, which instead showed ...
... discovered some of the genetic secrets that enable ... and disease, uncovering critical new information about forests ... says this genetic analysis will allow forest stewardship ... trees that could in time repel insects such ...
Cached Biology News:Corporate Safe Specialists Announces Addition to Sales Team 2Sea otter study reveals striking variability in diets and feeding strategies 2Sea otter study reveals striking variability in diets and feeding strategies 3UBC discovery unlocks tree genetics, gives new hope for pine beetle defense 2
BD Falcon 850 cm Smooth-surface TufRol Roller Bottle, tissue-culture treated polystyrene, blow-molded one-piece design, with easy on/off non-vented cap, packed in double bag. (20/ca) Packaging: ...
... The Yeast Protein Kit is a simple ... of yeast cells. The kit has been optimized ... but can be used for any fungus species ... The Zymolyase digestion procedure effectively generates spheroplasts of ...
... is a pleiotropic cytokine produced by activated ... OSM inhibits the growth of some tumour ... muscle and Kaposis sarcoma cell proliferation, cytokine ... lipoprotein receptor expression on hepatoma cells. Mouse ...
... used for heterologous protein expression in the ... cell line was derived from a primary culture ... melanogaster embryos (1). This versatile cell ... and is easily adapted to suspension culture. ...
Biology Products: